Balaji Trayodashang Guggul
Natural health product licensed in Canada
- Other names
- Balaji Trayodashang Guggul Vati
- Licence holder
- Bala Ji Trading Inc.
- NPN or DIN-HM
- 80124267
- Status
- Active licence
- Licence date
- 8 May 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Withania somnifera Source : Withania somnifera - racine | 16.66 mg | Not calculated |
| Commiphora wightii Source : Commiphora wightii - Gum oleoresin | 200 mg | Not calculated |
| Bos taurus Source : Bos taurus - Lait Extract : Matériel brut sec Extraction ratio : 1:1 Dry plant equivalent : 100 mg | 100 mg | Not calculated |
| Acacia nilotica | 16.66 mg | Not calculated |
| Juniperus communis Source : Juniperus communis - Fruit | 16.66 mg | Not calculated |
| Tinospora cordifolia | 16.66 mg | Not calculated |
| Asparagus racemosus | 16.66 mg | Not calculated |
| Tribulus terrestris Source : Tribulus terrestris - Fruit | 16.66 mg | Not calculated |
| Argyreia speciosa | 16.66 mg | Not calculated |
| Pluchea lanceolata | 16.66 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce | 16.66 mg | Not calculated |
| Curcuma zedoaria | 16.66 mg | Not calculated |
| Trachyspermum ammi | 16.66 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome | 16.66 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Cellulose microcristalline, Dioxyde de silicium, Croscarmellose de sodium, Phosphate dicalcique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Trayodashang Guggul is traditionally used in the Ayurveda to help relieve pain and swelling of the joints. Trayodashang Guggul is traditionally used in Ayurveda to help relieve nerve pain associated with grdhrasi (sciatica), and joint pain and joint swelling associated with arthritis. Trayodashang Guggul is traditionally used in Ayurveda to help relive symptoms of Sandhivata such as pain and swelling of the joints.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80124267
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Juniperus communis
Read the warning, when it applies and the studies cited
Juniper - Juniperus Communis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Mills et al. 2006).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have a kidney disorder (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Tribulus terrestris
Read the warning, when it applies and the studies cited
TRIBULUS - TRIBULUS TERRESTRIS
Route of administration: Oral
Cautions and warnings
Condition of application: All products except Vrsya (aphrodisiac for men).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Chen and Chen 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Traditional Chinese Medicine.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have qi or blood deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have low blood pressure or liver deficiency (Bensky et al. 2004; Chen and Chen 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (Bensky et al. 2004)
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except Mutrala (diuretic).
When using this product diuretic effect may occur.
- Foeniculum vulgare subsp. vulgare var. dulce
Read the warning, when it applies and the studies cited
BITTER FENNEL- FOENICULUM VULGARE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Essential oil and Tincture.
Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 29 November 2024
SWEET FENNEL -FOENICULUM VULGARE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.